Related Experiment Video

Updated: Oct 6, 2025

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.8K

Circular RNAs in the regulation of cardiac hypertrophy

Siyi Wu1, Lili Chen1, Xiang Zhou1

  • 1Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, China.

Molecular Therapy. Nucleic Acids
|January 17, 2022
PubMed

Insights

Circular RNAs are key regulators in cardiac hypertrophy, a condition that can lead to heart failure. Understanding circular RNA mechanisms offers potential new therapeutic targets for this cardiovascular disease.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Genetics

Background:

  • Cardiac hypertrophy is an adaptive response to pressure stress, but prolonged periods can cause heart failure.
  • Existing research on cardiac hypertrophy mechanisms and therapeutic targets is limited.
  • Non-coding RNAs, particularly circular RNAs, are increasingly recognized for their role in cardiovascular regulation.

Purpose of the Study:

  • To introduce the concept of circular RNA.
  • To review the role of circular RNA in cardiac hypertrophy.
  • To explore circular RNA as a potential therapeutic target for cardiac hypertrophy.

Main Methods:

  • Literature review focusing on circular RNA and cardiac hypertrophy.
  • Analysis of current research on molecular pathways involved.
  • Synthesis of findings to highlight therapeutic potential.

Main Results:

  • Circular RNAs are implicated as significant regulators in the development of cardiac hypertrophy.
  • Specific circular RNAs have been identified as potential biomarkers and therapeutic targets.
  • Further research is needed to fully elucidate the mechanisms.

Conclusions:

  • Circular RNAs represent a promising area for novel therapeutic strategies in cardiac hypertrophy.
  • Targeting circular RNAs could offer new avenues for treating pressure-induced heart conditions.
  • Continued investigation into circular RNA biology is crucial for advancing cardiovascular medicine.

Keywords:
cardiac hypertrophycircular RNAregulationspongetherapeutic target

More Related Videos

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.8K
Transverse Aortic Constriction in Mice08:25

Transverse Aortic Constriction in Mice

Published on: April 21, 2010

67.7K

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
84
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
95
Global Regulatory Systems01:28

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
106
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
84
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
551
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K